Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
December-2014 Volume 8 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2014 Volume 8 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report

Intestinal metaplasia of the renal pelvis: A case report and literature review

  • Authors:
    • Weimin Zhou
    • Kuangbiao Zhong
    • Jingrong Wang
    • Yonghong Gu
    • Lihua Huang
    • Zhiqiang Jiang
    • Leye He
  • View Affiliations / Copyright

    Affiliations: Department of Urology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China, Department of Pathology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China, Center for Medical Experiments, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China
  • Pages: 2664-2668
    |
    Published online on: September 18, 2014
       https://doi.org/10.3892/ol.2014.2547
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Metaplastic changes in the renal pelvis are infrequent and may be malignant transformations to adenocarcinoma. The current study reports a case of intestinal metaplasia in the right renal pelvis, which was associated with staghorn calculi, in a 56‑year‑old female. The patient underwent a percutaneous nephrolithotomy. Immunohistochemical assessment of the mucosa of the renal pelvis revealed the positive expression of carcinoembryonic antigen, cytokeratin (CK)‑7 and CK20, but negative expression for CK5/6 and vimentin. Furthermore, Ki67 expression was diffusely positive, while p53 was negative. Unlike other previously reported cases, the patient opted for active surveillance as opposed to radical nephrectomy, following the removal of the calculi. No evidence of progression was observed after three years of follow‑up. Therefore, etiological treatment and close follow‑up may be a suitable treatment option for localized intestinal metaplasia.

Introduction

The renal pelvis does not contain an intestinal or squamous epithelium, but is normally lined by a urothelium. However, under rare circumstances, particularly those of chronic infection and urinary calculi, the transitional cell epithelium may undergo phenotypical changes, usually in the form of intestinal metaplasia, which are considered to be closely associated with adenocarcinoma (1–5). In addition, for simple intestinal metaplasia of the renal pelvis without abnormal renal function, it has not been well established whether eliminating such stimulating factors may reverse the pathological changes. The present study describes a case of intestinal metaplasia of the renal pelvis where a panel of immunohistochemical biomarkers were applied to aid in the determination of the origin and prognosis of the malignancy. A review of the previously reported cases is also presented. Written informed consent was obtained from the patient.

Case report

Patient diagnosis

A 56-year-old female was admitted to the Third Xiangya Hospital of Central South University (Changsha, China) in October 2010 due to backache on the right side that had persisted for one year. The patient had a history of controlled hypertension and recurrent right kidney stones, and therefore, had undergone extracorporeal shock wave lithotripsy on several occasions over ~10 years previously. The physical examination was unremarkable. Abdominal X-ray revealed right renal staghorn calculi (Fig. 1A). Contrast enhanced computerized tomography (CT) demonstrated slight contrast enhancement in a lesion measuring 6×10 mm in diameter in the right renal pelvis (Fig. 1B), indicating that the tumor could not be excised. No enlarged lymph nodes were observed on the CT image. Urine analysis revealed the values of 20 white blood cells per high-power field (normal, <10 white blood cells per high-power field), 35 red blood cells per high-power field (normal, <5 red blood cells per high-power field), proteinuria of 50 mg/l (normal, <100 mg/ml) and no bacteria in urine culture. The serum levels of α-fetoprotein (AFP), carcinoembryonic antigen (CEA) and carbohydrate antigen (CA)19-9 were normal.

Figure 1

Imaging diagnosis of the patient. (A) Abdominal X-ray revealed right renal staghorn calculi. (B) Contrast enhanced computed tomography demonstrated slight contrast enhancement in the right renal pelvis (white triangle). (C) Mucosal changes under ureteroscopy in the renal pelvis (black arrows).

Treatment and follow-up

Percutaneous nephrolithotomy was subsequently performed. Upon nephroscopy, a minor local protrusion, but no evident lump was observed in an area measuring 10×15 mm in the mucosa of the renal pelvis (Fig. 1C). Biopsies were conducted four times for the pathological analysis of the suspicious lesions. Following the removal of the calculi, the recovery was uneventful, and the patient was discharged from the hospital six days later. The pathological diagnosis was of significant intestinal metaplasia, and radical nephrectomy or local lesions electrovaporization was subsequently recommended, however the patient selected active surveillance. To date, subsequent to three years of follow-up, the patient is alive, with no evidence of tumor progression observed on CT scan and with normal serum AFP, CEA and CA19-9 levels.

Pathological findings

Hematoxylin-eosin (HE) staining revealed that the biopsied tissues were composed of significant intestinal metaplasia with abundant goblet cells (Fig. 2A). Part of the glandular epithelium exhibited low-grade dysplasia. No squamous metaplasia or invasive adenocarcinoma was observed. In addition to the glandular zone, infiltration with lymphocytes and plasma cells was observed. Staining with alcian blue-periodic acid Schiff revealed abundant mucin within the cytoplasm of the glandular epithelium (Fig. 2B). In all the biopsies, no normal transitional epithelium was observed. Immunohistochemical analysis revealed positive expression for CEA, CK7 and CK20, however, negative expression was observed for CK5/6 and vimentin in the metaplastic urothelium (Fig. 2C–G). Furthermore, Ki67 expression was diffusely positive with an mean labeling index of 12% in 10 random microscopic fields, whereas p53 was negative in all instances (Fig. 2H and I).

Figure 2

Histological features of the renal pelvis. (A) Hematoxylin-eosin staining revealing significant intestinal metaplasia and inflammation infiltration; part of the glandular epithelium showed low-grade dysplasia. (B) Alcian blue-periodic acid Schiff (AB-PAS) staining revealing abundant mucin within the cytoplasm of the glandular epithelium. Immunohistochemical staining showing (C) the positive expression of carcinoembryonic antigen; (D) CK5/6-negative expression; (E and F) the positive expression of CK7 (weak) and CK20 (strong); (G) vimentin-negative expression; (H) the diffusely-positive nuclear staining of Ki67; and (I) p53-negative expression. Original magnification, ×200. CK, cytokeratin.

Discussion

Cases of metaplasia of the renal pelvis without associated malignancy are extremely rare, and to the best of our knowledge, only 18 cases have been previously reported in the English language literature (Table I) (1,6–17). A review of this literature showed that the mean age of these patients was 51.2±14.0 years and the male to female ratio was 2.6:1, with a male predominance. In total, eight of the 18 subjects exhibited intestinal metaplasia (single intestinal or combined with squamous metaplasia). Almost all of the reported subjects had experienced a long history of irritations of the renal pelvis, the majority of which were chronic urinary tract infections, hydronephrosis and calculus. Of the reported subjects, 15 patients (83.3%) exhibited calculi and more than half of the subjects suffered from a large calculus or multiple calculi of the renal pelvis (11/18; 61.1%). Therefore, the long-term effects of chronic irritations are likely to be associated with metaplasia of the urothelium of the renal pelvis.

Table I

Reports of metaplasia of the renal pelvis without associated malignancy.

Table I

Reports of metaplasia of the renal pelvis without associated malignancy.

First author/s, year (ref.)Gender/age, yearsType of metaplasiaCalculusAssociated condition
Foot, 1944 (6)F/54Intestinal++Pyonephrosis
Torassa, 1948 (7)M/46Intestinal++Pyonephrosis and multiple abscesses
Maclean and Fowler, 1956 (8)F/39Intestinal++Chronic pyelonephritis
Krag and Alcott, 1957 (9)M/52Intestinal and squamous++Hydronephrosis and pyonephrosis
Gordan, 1963 (10)M/55Intestinal and squamous+Chronic pyelonephritis
M/50Glandular−Bladder dysfunction and pyonephrosis
Towers, 1963 (11)F/55Cystic and intestinalUPyonephrosis
Salm, 1969 (12)M/55Intestinal and squamous++Phronic pyelonephritis
Ward, 1971 (13)M/49Glandular and squamous++Pyonephrosis.
M/40Glandular+U
M/64Squamous and glandular+Pyonephrosis
Blacklock et al, 1983 (14)M/61Squamous and mucinous++Chronic pyelonephritis
M/21Squamous and mucinous++Chronic pyelonephritis and hydronephrosis
Lam and Choi, 1995 (15)M/79Mucinous++Chronic pyelonephritis and nephrosclerosis
Mathur et al, 2004 (16)M/40Mucinous++Chronic pyelonephritis
Deniz et al, 2010 (1)M/32Intestinal+Chronic pyelonephritis and renal atrophy
Siderits et al, 2012 (17)F/74Squamous−Renal obstruction and pyohydronephrosis
Present caseF/56Intestinal++Pyonephrosis

[i] +, simple calculus; ++, large calculus or multiple calculi; −, no history of calculus; U, unknown; F, female; M, male.

The exact mechanism by which intestinal metaplasia occurs is not entirely understood, however, it has been hypothesized to be associated with the endodermal origin of the embryonal cloaca and intestine (12). Therefore, the divergent metaplastic potentialities of the urinary transitional epithelium to squamous, mucinous or intestinal metaplasia can be readily explained (12). In addition, intestinal metaplasia within the upper urinary tract is extremely unusual and may prompt the surgeon to consider a primary intestinal pathological cause (13). Usually, a normal urothelium expresses simple epithelial cytokeratins, including CK5/6, CK7 and CK20, while in gastroenteric tumors, this does not occur (1,21). In the present case, CK5/6 expression was absent in the metaplastic epithelium, however, stronger CK20 expression was present. Therefore, we proposed that the renal pelvis epithelium underwent changes in phenotype in the intestinal metaplasia and may not be of primary intestinal pathology.

Precancerous changes are hypothesized to contribute to the metaplastic changes in the urothelium, and adenocarcinomas may arise from metaplastic changes of an epithelium that is potentially unstable (18). The presence of adenocarcinoma in combination with intestinal metaplasia has been frequently observed (3–5,19,20). Similarly, with intestinal metaplasia of the renal pelvis, a significant history of chronic irritations, including inflammation and calculi, are also present in the majority of cases of adenocarcinoma (2–4,19). Spires et al (2) reviewed a total of 59 cases of adenocarcinoma and observed that tubulovillous and mucinous tissue types, which accounted for 93% of cases, were morphologically similar to intestinal tumors, and therefore may arise from foci of intestinal metaplasia. Considering this, adenocarcinomas are likely to develop from the progressive transformation of these metaplastic cells in a stepwise adenoma-carcinoma sequence, possibly in a similar manner to colonic carcinogenesis (3). Notably, these conclusions were predominantly based on the synchronous presence of cancer in the specimen, which also contained metaplastic changes. In addition, in numerous other cases, the neoplasms arose without any preceding metaplastic changes (21,22). Therefore, the malignancy of metaplasia in the renal pelvis remains controversial.

The occurrence of metaplasia in the renal pelvis without an associated malignancy is rare, as reviewed previously (16). In the bladder, cystitis glandularis and intestinal metaplasia have been proposed to represent precursors of bladder adenocarcinoma (23,24). However, this notion has now been challenged. By observing 53 patients for 10 years and 136 patients for 2.6 years, respectively, Corica et al (25) and Smith et al (24) revealed that cystitis glandularis or intestinal metaplasia had no tendency towards carcinoma. The identification and removal of the causes of cystitis glandularis, such as upper urinary tract obstruction, were considered as the most important management methods (26). However, in the renal pelvis, further evaluation ir required to determine whether intestinal metaplasia has the potential to progress to adenocarcinoma and whether etiological treatment may reverse the pathological changes. To date, no reports have traced progression to malignancy in patients with a final diagnosis of intestinal metaplasia of the renal pelvis.

Elevated serum levels of AFP, CEA and CA19-9 have been reported in several studies of adenocarcinoma of the renal pelvis and were considered to be effective prognostic biomarkers (22,27). In the current case, the serum levels of AFP, CEA and CA19-9 were normal and remained normal subsequent to three years of follow-up. However, immunohistochemical staining revealed strong CEA expression. In addition, the expression of tumor markers p53 and Ki67 was also evaluated in the tissue. The results revealed p53-negative expression, but diffusely-positive expression for Ki67, suggesting a potential proliferation ability of the intestinal metaplasia of the renal pelvis. Notably, in this case, the biopsies that were obtained were superficial to a certain extent, and it is possible that the potential adenocarcinoma below the mucosa may have been overlooked, as the CT scan suggested limited lesions in the renal pelvis. Due to the poor prognosis of adenocarcinoma of the renal pelvis, for which the majority of patients succumb to the disease within two to five years (27), radical nephrectomy or local lesions electrovaporization remained the recommended treatment for the current patient following the removal of the calculi by percutaneous nephrolithotomy; however, the patient selected active surveillance. Subsequent to three years of follow-up by CT imaging every six months, no further progression was observed. The surveillance will continue for the foreseeable future.

In conclusion, intestinal metaplasia of the renal pelvis is closely associated with chronic stimuli, particularly from complex calculi and urinary tract infections. It remains controversial whether intestinal metaplasia may progress to adenocarcinoma. Etiological treatment and close follow-up may be suitable and practical for local intestinal metaplasia, however this option may pose an increased risk. Future studies examining the long-term outcomes in a larger series of patients with intestinal metaplasia of the renal pelvis may be of value to further delineate the association between intestinal metaplasia and renal pelvis carcinoma.

Acknowledgements

This study was supported by the Fundamental Research Funds for the Central Universities of Central South University (grant no. 72150050368).

References

1 

Deniz K, Kala M and Kaya R: Intestinal metaplasia of the renal pelvis. Urol J. 7:287–289. 2010.

2 

Spires SE, Banks ER, Cibull ML, et al: Adenocarcinoma of renal pelvis. Arch Pathol Lab Med. 117:1156–1160. 1993.

3 

Sagnotta A, Dente M, Socciarelli F, et al: Primary adenocarcinoma of the renal pelvis: histologic features of a stepwise process from intestinal hyperplasia to dysplasia in a patient with chronic renal abscess. Int J Surg Pathol. 22:182–185. 2013.

4 

Tsuzuki T, Kouketsu H, Ono K, Kobayashi H and Obata K: Primary adenocarcinoma of the renal pelvis with special reference to histochemical observations. Pathol Int. 46:791–796. 1996.

5 

Toyoda H, Mabuchi T and Fukuda K: Mucinous cystadenoma with malignant transformation arising in the renal pelvis. Pathol Int. 47:174–178. 1997.

6 

Foot NC: Glandular metaplasia of the epithelium of the urinary tract. South Med J. 37:137–142. 1944.

7 

Torassa GL Jr: Pyelitis glandularis. J Urol. 60:393–397. 1948.

8 

Maclean JT and Fowler VB: Pathology of tumors of the renal pelvis and ureter. J Urol. 75:384–415. 1956.

9 

Krag DO and Alcott DL: Glandular metaplasia of the renal pelvis; report of a case. Am J Clin Pathol. 27:672–680. 1957.

10 

Gordon A: Intestinal metaplasia of the urinary tract epithelium. J Pathol Bacteriol. 85:441–444. 1963.

11 

Towers RP: Aspects of metaplasia in genito-urinary pathology. J Ir Med Assoc. 53:179–183. 1963.

12 

Salm R: Combined intestinal and squamous metaplasia of the renal pelvis. J Clin Pathol. 22:187–191. 1969.

13 

Ward AM: Glandular neoplasia within the urinary tract. The aetiology of adenocarcinoma of the urothelium with a review of the literature I Introduction: the origin of glandular epithelium in the renal pelvis, ureter and bladder. Virchows Arch A Pathol Pathol Anat. 352:296–311. 1971.

14 

Blacklock AR, Geddes JR and Black JW: Mucinous and squamous metaplasia of the renal pelvis. J Urol. 130:544–545. 1983.

15 

Lam KY and Choi CH: Massive enlargement of the kidney in glandular metaplasia of the renal pelvis. Nephron. 69:91–92. 1995.

16 

Mathur S, Singh MK, Rao SI and Seth A: Mucinous metaplasia of the renal pelvic epithelium in a case of recurrent urolithiasis and pyelonephritis. Urol Int. 72:355–357. 2004.

17 

Siderits RH, Fingerman J, Hazra A, et al: Renal pelviceal keratinizing squamous metaplasia with sparing of pyramidal zones. Case Rep Urol. 2012:2427802012.

18 

Manunta A, Vincendeau S, Kiriakou G, Lobel B and Guille F: Non-transitional cell bladder carcinomas. BJU Int. 95:497–502. 2005.

19 

Park S, Meng MV, Greenberg MS, Deng DY and Stoller ML: Muconephrosis. Urology. 60:3442002.

20 

Rao P, Pinheiro N Jr, Franco M, et al: Pseudomyxoma peritonei associated with primary mucinous borderline tumor of the renal pelvicalyceal system. Arch Pathol Lab Med. 133:1472–1476. 2009.

21 

Takehara K, Nomata K, Eguchi J, et al: Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder. Int J Urol. 11:1016–1018. 2004.

22 

Yang K, Zheng XY, Wang YL, Zhao K and Jiang H: Alpha-fetoprotein and carbohydrate antigen 19–9 producing advanced adenocarcinoma of renal pelvis and ureter. Can Urol Assoc J. 7:E750–E753. 2013.

23 

Williamson SR, Lopez-Beltran A, Montironi R and Cheng L: Glandular lesions of the urinary bladder: clinical significance and differential diagnosis. Histopathology. 58:811–834. 2011.

24 

Smith AK, Hansel DE and Jones JS: Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma. Urology. 71:915–918. 2008.

25 

Corica FA, Husmann DA, Churchill BM, et al: Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology. 50:427–431. 1997.

26 

Li A, Liu S, Lu H, et al: Clinical character of cystitis glandularis accompanied with upper urinary tract obstruction. Can Urol Assoc J. 7:E708–E710. 2013.

27 

Ye YL, Bian J, Huang YP, et al: Primary mucinous adenocarcinoma of the renal pelvis with elevated CEA and CA19-9. Urol Int. 87:484–488. 2011.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhou W, Zhong K, Wang J, Gu Y, Huang L, Jiang Z and He L: Intestinal metaplasia of the renal pelvis: A case report and literature review. Oncol Lett 8: 2664-2668, 2014.
APA
Zhou, W., Zhong, K., Wang, J., Gu, Y., Huang, L., Jiang, Z., & He, L. (2014). Intestinal metaplasia of the renal pelvis: A case report and literature review. Oncology Letters, 8, 2664-2668. https://doi.org/10.3892/ol.2014.2547
MLA
Zhou, W., Zhong, K., Wang, J., Gu, Y., Huang, L., Jiang, Z., He, L."Intestinal metaplasia of the renal pelvis: A case report and literature review". Oncology Letters 8.6 (2014): 2664-2668.
Chicago
Zhou, W., Zhong, K., Wang, J., Gu, Y., Huang, L., Jiang, Z., He, L."Intestinal metaplasia of the renal pelvis: A case report and literature review". Oncology Letters 8, no. 6 (2014): 2664-2668. https://doi.org/10.3892/ol.2014.2547
Copy and paste a formatted citation
x
Spandidos Publications style
Zhou W, Zhong K, Wang J, Gu Y, Huang L, Jiang Z and He L: Intestinal metaplasia of the renal pelvis: A case report and literature review. Oncol Lett 8: 2664-2668, 2014.
APA
Zhou, W., Zhong, K., Wang, J., Gu, Y., Huang, L., Jiang, Z., & He, L. (2014). Intestinal metaplasia of the renal pelvis: A case report and literature review. Oncology Letters, 8, 2664-2668. https://doi.org/10.3892/ol.2014.2547
MLA
Zhou, W., Zhong, K., Wang, J., Gu, Y., Huang, L., Jiang, Z., He, L."Intestinal metaplasia of the renal pelvis: A case report and literature review". Oncology Letters 8.6 (2014): 2664-2668.
Chicago
Zhou, W., Zhong, K., Wang, J., Gu, Y., Huang, L., Jiang, Z., He, L."Intestinal metaplasia of the renal pelvis: A case report and literature review". Oncology Letters 8, no. 6 (2014): 2664-2668. https://doi.org/10.3892/ol.2014.2547
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team